Thermo Fisher Scientific (TMO) Income from Non-Controlling Interests (2013 - 2026)
Thermo Fisher Scientific (TMO) posted quarterly Income from Non-Controlling Interests of $5.0 million for Q2 2026, up 150.0% year-over-year from $2.0 million in Q2 2025, and little changed on a QoQ basis from $5.0 million in Q1 2026.
Thermo Fisher Scientific (TMO) Income from Non-Controlling Interests (2013 - 2026) Analysis & Trends
Thermo Fisher Scientific has reported Income from Non-Controlling Interests for 6 years, with the latest figure at $5.0 million in Q2 2026.
- Income from Non-Controlling Interests for Q2 2026 came in at $5.0 million, up 150.0% year-over-year; the trailing twelve-month figure through Jun 2026 was $21.0 million (changed N/A YoY), and the FY2025 annual result was $17.0 million, up 466.67% from the prior year.
- Income from Non-Controlling Interests held at $5.0 million in Q2 2026, from $5.0 million in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $6.0 million in Q2 2024 and troughed at -$24.0 million in Q4 2023.
- A 5-year average of $58823.5 and a median of $4.0 million in 2022 frame the typical range for Income from Non-Controlling Interests.
- The widest annual swing landed in 2023, when Income from Non-Controlling Interests slumped 1100.0%; it then soared 500.0% in 2024.
- A 5-year view of Income from Non-Controlling Interests shows it stood at -$2.0 million in 2022, then slumped by 1100.0% to -$24.0 million in 2023, then jumped by 75.0% to -$6.0 million in 2024, then surged by 200.0% to $6.0 million in 2025, then fell by 16.67% to $5.0 million in 2026.
- Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were $5.0 million in Q2 2026, $5.0 million in Q1 2026, and $6.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 2.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 400,000.00 |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | 14.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 5.00 Mn |
| Mar 28, 2026 | 5.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 27, 2025 | 5.00 Mn |
| Jun 28, 2025 | 2.00 Mn |
| Mar 29, 2025 | 4.00 Mn |
| Dec 31, 2024 | -6.00 Mn |
| Jun 29, 2024 | 6.00 Mn |
| Mar 30, 2024 | 4.00 Mn |
| Dec 31, 2023 | -24.00 Mn |
| Sep 30, 2023 | -20.00 Mn |
| Jul 1, 2023 | 1.00 Mn |
| Apr 1, 2023 | 3.00 Mn |
| Dec 31, 2022 | -2.00 Mn |
| Oct 1, 2022 | 3.00 Mn |
| Jul 2, 2022 | 4.00 Mn |
| Apr 2, 2022 | 5.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Oct 2, 2021 | 1.00 Mn |
| Jul 3, 2021 | 1.00 Mn |